Mark Yarchoan

AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma

Amit G. Singal, Josep M. Llovet, Mark Yarchoan et al. · Hepatology · 2023 · 1.7K citations · Full text

Medicine, Oncology, Surgery +17

PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers

Mark Yarchoan, Lee A. Albacker, Alexander C. Hopkins et al. · JCI Insight · 2019 · 538 citations · Full text

Medicine, Cancer Biology, Oncology +17

Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity

Won Jin Ho, Qingfeng Zhu, Jennifer N. Durham et al. · Nature Cancer · 2021 · 346 citations · Full text

Medicine, Oncology, Pharmacology +17

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias

Mark Yarchoan, Sharon X. Xie, Mitchel A. Kling et al. · Brain · 2012 · 268 citations · Full text

Medicine, Neurology, Pathology +17